Does BOTULINUM TOXIN TYPE A Cause Nasopharyngitis? 431 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 431 reports of Nasopharyngitis have been filed in association with BOTULINUM TOXIN TYPE A (Jeuveau). This represents 11.5% of all adverse event reports for BOTULINUM TOXIN TYPE A.
431
Reports of Nasopharyngitis with BOTULINUM TOXIN TYPE A
11.5%
of all BOTULINUM TOXIN TYPE A reports
423
Deaths
351
Hospitalizations
How Dangerous Is Nasopharyngitis From BOTULINUM TOXIN TYPE A?
Of the 431 reports, 423 (98.1%) resulted in death, 351 (81.4%) required hospitalization, and 357 (82.8%) were considered life-threatening.
Is Nasopharyngitis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BOTULINUM TOXIN TYPE A. However, 431 reports have been filed with the FAERS database.
What Other Side Effects Does BOTULINUM TOXIN TYPE A Cause?
Off label use (1,785)
Drug ineffective (1,175)
Drug intolerance (1,004)
Product use in unapproved indication (950)
Headache (797)
Migraine (775)
Maternal exposure during pregnancy (716)
Pain (714)
Hypoaesthesia (703)
Nausea (665)
What Other Drugs Cause Nasopharyngitis?
ADALIMUMAB (13,753)
ETANERCEPT (12,421)
METHOTREXATE (8,046)
TOFACITINIB (7,781)
SECUKINUMAB (7,022)
TOCILIZUMAB (6,664)
RITUXIMAB (6,321)
ABATACEPT (6,143)
INFLIXIMAB (5,353)
CERTOLIZUMAB PEGOL (5,295)
Which BOTULINUM TOXIN TYPE A Alternatives Have Lower Nasopharyngitis Risk?
BOTULINUM TOXIN TYPE A vs BREMELANOTIDE
BOTULINUM TOXIN TYPE A vs BRENTUXIMAB
BOTULINUM TOXIN TYPE A vs BRENTUXIMAB VEDOTIN
BOTULINUM TOXIN TYPE A vs BREO ELLIPTA
BOTULINUM TOXIN TYPE A vs BREXANOLONE